Growth Metrics

Novartis Ag (NVS) Total Debt (2016 - 2025)

Historic Total Debt for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $33.5 billion.

  • Novartis Ag's Total Debt rose 1330.83% to $33.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $33.5 billion, marking a year-over-year increase of 1330.83%. This contributed to the annual value of $33.5 billion for FY2025, which is 1330.83% up from last year.
  • Per Novartis Ag's latest filing, its Total Debt stood at $33.5 billion for Q4 2025, which was up 1330.83% from $30.1 billion recorded in Q3 2025.
  • Novartis Ag's Total Debt's 5-year high stood at $35.9 billion during Q1 2021, with a 5-year trough of $23.5 billion in Q3 2023.
  • In the last 5 years, Novartis Ag's Total Debt had a median value of $29.4 billion in 2022 and averaged $29.1 billion.
  • As far as peak fluctuations go, Novartis Ag's Total Debt crashed by 1899.62% in 2021, and later skyrocketed by 2886.17% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Total Debt stood at $29.2 billion in 2021, then decreased by 10.35% to $26.2 billion in 2022, then dropped by 5.98% to $24.6 billion in 2023, then rose by 20.26% to $29.6 billion in 2024, then grew by 13.31% to $33.5 billion in 2025.
  • Its Total Debt stands at $33.5 billion for Q4 2025, versus $30.1 billion for Q3 2025 and $30.8 billion for Q2 2025.